ArticleDiseases (Basel, Switzerland)2026
Temporal Distribution of Elevated-HbA1c Records and a Young-Adult Multiorgan Biomarker Profile in Diabetes: A Retrospective Observational Study.
Article in Diseases (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesDiabetes-related renal, lipid, and hepatic abnormalities are clinically important, but their distribution may be heterogeneous and is not fully represented by HbA1c alone. We characterized the temporal age and sex composition of elevated-HbA1c records and, separately, the multiorgan biomarker profile of a 2022 young-adult subcohort.
methodsThis retrospective observational study analyzed 1160 patient-year records classified as having elevated HbA1c from 2019-2022. These were annual record strata rather than 1160 unique individuals or a cohort followed as participants aged. A separate cross-sectional biomarker subcohort comprised 49 adults aged 18-29 years in 2022, of whom 26 were source-classified as having elevated HbA1c. Annual age and sex distributions were assessed using chi-square tests. Biomarker abnormalities were summarized with biomarker-specific denominators and Wilson 95% confidence intervals; sex comparisons were exploratory and used Fisher's exact tests, odds ratios, φ coefficients, and Benjamini-Hochberg false-discovery-rate correction.
resultsAge composition differed across calendar years (χ
conclusionsThe study demonstrates temporal heterogeneity in elevated-HbA1c record composition and a descriptive young-adult biomarker profile dominated by dyslipidemia, albuminuria, selected renal-metabolic abnormalities, and ALT elevation. Because the archived dataset did not retain the paired continuous HbA1c-biomarker data or older-age biomarker data needed for dose-response or cross-age comparisons, the findings should not be interpreted as establishing an HbA1c-linked multiorgan causal relationship. They support the value of integrated organ-risk assessment and the need for prospective patient-level analyses across HbA1c and age strata.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.